A detailed history of Beck Mack & Oliver LLC transactions in Pfizer Inc stock. As of the latest transaction made, Beck Mack & Oliver LLC holds 86,006 shares of PFE stock, worth $2.22 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
86,006
Previous 86,000 0.01%
Holding current value
$2.22 Million
Previous $2.41 Million 3.45%
% of portfolio
0.06%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $166 - $188
6 Added 0.01%
86,006 $2.49 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $50,520 - $59,200
-2,000 Reduced 2.27%
86,000 $2.41 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $653 - $848
-25 Reduced 0.03%
88,000 $2.53 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $142,383 - $166,431
-4,437 Reduced 4.8%
88,025 $2.92 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $2,012 - $2,457
-46 Reduced 0.05%
92,462 $4.05 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $2,140 - $2,537
46 Added 0.05%
92,508 $4.85 Million
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $2,983 - $3,831
-76 Reduced 0.08%
92,462 $3.98 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $2,729 - $3,091
76 Added 0.08%
92,538 $3.62 Million
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $26,792 - $30,216
-800 Reduced 0.86%
92,462 $3.35 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $2,209 - $2,808
-66 Reduced 0.07%
93,262 $3.43 Million
Q3 2019

Nov 06, 2019

SELL
$32.49 - $42.13 $107,217 - $139,029
-3,300 Reduced 3.42%
93,328 $3.35 Million
Q2 2018

Jul 25, 2018

SELL
$32.98 - $35.16 $1,319 - $1,406
-40 Reduced 0.04%
96,628 $0
Q1 2018

Apr 25, 2018

SELL
$31.91 - $37.02 $43,397 - $50,347
-1,360 Reduced 1.39%
96,668 $0
Q3 2017

Oct 27, 2017

BUY
$31.0 - $34.15 $3.04 Million - $3.35 Million
98,028
98,028 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Beck Mack & Oliver LLC Portfolio

Follow Beck Mack & Oliver LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Mack & Oliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Mack & Oliver LLC with notifications on news.